Formoterol Fumarate: Following inhaled administration ... Inform patients that long-term use of ICS may increase the risk of some eye problems (cataracts or glaucoma); consider regular eye ...

BOSTON -- Inhaled corticosteroids (ICS) combined either with formoterol (Foradil) or short-acting beta-agonists (SABA) for asthma treatment were associated with reduced risks of severe ...

Trimbow (beclometasone+formoterol+glycopyrronium) combines an inhaled corticosteroid (ICS), a long-acting beta adrenoceptor agonist (LABA) and a long-acting muscarinic antagonist (LAMA ...

This was a prospective, open-label, multicentre, randomised, parallel-group comparison of formoterol monotherapy with a fixed combination of ipratroprium bromide and fenoterol. Patients were ...

Seretide/Advair (fluticasone propionate + salmeterol; GlaxoSmithKline) and Symbicort (budesonide + formoterol fumarate dihydrate; AstraZeneca), which are ICS–LABA combinations, are other popular ...

Current controller drugs for asthma include ICS, LABA, LTRA ... Current benefits from inhaled LABA such as salmeterol and formoterol in the treatment of asthma continue to outweigh risks, which ...

Glycopyrrolate 9mcg, formoterol fumarate 4.8mcg; per inhalation; metered-dose inhaler. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in ...